Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Clinical trial NCT01106092 · COMPLETED

Trial details

NCT number: NCT01106092
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Tetanus Hepatitis B Whole Cell Pertussis Diphtheria Poliomyelitis Vaccines

Start date: 2010-05-13
Primary completion: 2010-09-02
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.